Are these 3 Biotech Stocks Undervalued?
The biotech theme could rise in 2025. Here are three value picks to help you ride the wave.
While the biotech theme took a bit of a beating in the aftermath of Donald Trump’s election win, principally due to concerns around vaccine skeptic Robert F Kennedy Jr. becoming his health secretary, investors have since been buoyed by Trump’s Food and Drug Administration pick.
Marty Makary is a surgeon and proponent of RFK Jr.’s plan to tackle chronic d…
Keep reading with a 7-day free trial
Subscribe to Foresight to keep reading this post and get 7 days of free access to the full post archives.